Scientific Consultanting in:
- Separation Science, Chirality and Stereochemistry
- Pharmaceutical Process R&D
- High Throughput Experimentation
- Pharmaceutical & Biopharmaceutical Industry
- New Research Technologies
- Strategic Planning
- Scientific Publication and Communication Strategy
Christopher J. Welch is a principal with Welch Innovation, LLC, an independent research and consulting firm. He serves as the Executive Director of the Indiana Consortium for Analytical Science and Engineering (ICASE), a joint venture between Purdue, Notre Dame and Indiana University (link). Chris also serves on the Scientific Advisory Board for Snapdragon Chemistry, Novilytic, LLC, the IU Department of Chemistry and on the board of directors for Pacifichem, Inc. He has worked in a variety of fields including discovery synthesis of agrochemicals (Velsicol-Sandoz), development of reagents for improved immunodiagnostic assays (Abbott Laboratories), development and commercialization of chromatographic stationary phases, reagents and enantioselective catalysts within a small chemical business environment (Regis Technologies) invention and application of new purification, analysis and high throughput experimentation technologies for pharmaceutical process research (Merck & Co.) and as a Science Advisor for the US FDA. While at Merck, Dr. Welch created and administered Merck's postdoctoral research fellows program and managed a multi-million-dollar fund and research network that identified and evaluated new enabling technologies for pharmaceutical discovery and development. Dr. Welch has authored more than 300 scientific publications and patents. He is co-founder of the journal, Enantiomer, and a member of the editorial advisory board for Chirality and ACS Central Science. Chris is a Fellow of the American Chemical Society (ACS) and the American Association for the Advancement of Science (AAAS) and the recipient of a number of awards, including the 2013 Chirality Medal (2015).
For a complete listing, see the GoogleScholar page here.